Ligand validation:6XL4

ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6XL4_ANP_D_1102	83%	46%	0.091	0.95	1.06	1.04	3	2	0	0	100%	1
5CNO_ANP_A_1001	95%	20%	0.078	0.982	2.34	1.11	5	4	0	0	100%	1
7JXQ_ANP_D_1102	94%	45%	0.083	0.984	0.94	1.16	1	4	0	0	100%	1
4ZSE_ANP_C_3001	88%	13%	0.085	0.96	1.85	2.07	8	6	2	0	100%	1
7JXP_ANP_B_1101	88%	41%	0.093	0.968	1.04	1.27	3	5	0	0	100%	1
6DUK_ANP_E_1102	87%	5%	0.107	0.978	2.29	2.88	12	8	0	0	100%	1
8PS7_ANP_A_704	100%	43%	0.023	0.994	1.15	1.05	4	2	0	0	100%	1
9AVR_ANP_A_501	100%	36%	0.034	0.991	1.05	1.46	2	5	2	0	100%	1
4BRA_ANP_A_1394	100%	12%	0.037	0.993	2.3	1.8	10	6	3	0	100%	1
4DFX_ANP_E_402	100%	32%	0.036	0.989	1.35	1.35	4	2	1	0	100%	1
4BRD_ANP_B_1396	100%	16%	0.041	0.994	1.66	2.04	4	10	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.